Not applicableNot Yet RecruitingNCT07706010
What this trial is testing
Cardiovascular Risk in T2DM With MAFLD: A Cohort Study
Who this might be right for
Type 2 Diabetes (T2DM)Metabolic Dysfunction-Associated Steatotic Liver Disease
The Affiliated Hospital of Hangzhou Normal University 7,000